Audited Results of Orchid Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	921.93	819.37	665.90	556.97	450.69
Manufacturing Expenses	64.98	62.92	61.26	52.74	39.31
Personnel Expenses	86.36	69.64	65.35	60.21	64.40
Selling Expenses	0.03	0.03	0.04	0.04	0.02
Administrative Expenses	83.41	77.70	58.45	59.93	48.31
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	798.40	708.69	582.28	499.72	392.81
Operating Profit	123.53	110.68	83.62	57.26	57.89
Other Recurring Income	31.93	30.39	19.43	9	6.48
Adjusted PBDIT	155.46	141.07	103.05	66.26	64.36
Financial Expenses	14.54	16.33	32.23	87.02	51.34
Depreciation	34.44	33.22	54.79	32.01	108.90
Other Write offs	0	0	0	0	0
Adjusted PBT	106.48	91.52	16.04	-52.77	-95.87
Tax Charges	0	-3.23	0	0	0
Adjusted PAT	106.48	94.75	16.04	-52.77	-95.87
Non Recurring Items	0	0	38.15	47.96	-21.28
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	106.48	94.75	54.19	-4.81	-117.15
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	-1,881.90	-1,987.93	-2,082.45	-2,138.10	-2,133.89

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article